Genotypic characterization of Haemophilus influenzae isolates from paediatric patients in Japan

Yoko Adachi1, Mariko Ando1, Miyuki Morozumi1

  • 1Department of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Insights

β-lactamase-negative ampicillin-resistant (BLNAR) Haemophilus influenzae is common in respiratory infections. This study genetically characterized BLNAR isolates, revealing diverse strains in pneumonia and acute otitis media, unlike the predominant Hib in meningitis.

Area of Science:

  • Medical Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • β-lactamase-negative ampicillin-resistant (BLNAR) *Haemophilus influenzae* is a significant pathogen, particularly in Japan.
  • BLNAR strains pose challenges in treating respiratory tract infections.

Purpose of the Study:

  • To genetically characterize BLNAR *Haemophilus influenzae* isolates.
  • To determine associations between genotypic characteristics and resistance patterns.
  • To investigate the epidemiology of BLNAR *H. influenzae* in paediatric infections.

Main Methods:

  • Collected 191 *H. influenzae* isolates from paediatric pneumonia, acute otitis media (AOM), and meningitis cases (2000-2011).
  • Performed BLNAR-PCR for β-lactam resistance and multilocus sequence typing (MLST) for genotypic characterization.
  • Analyzed sequence types (STs) using eBURST v3.

Main Results:

  • 46.1% (88/191) of isolates were BLNAR.
  • BLNAR strains were prevalent in pneumonia (60.7%) and AOM (48.5%) but less so in meningitis (29.0%).
  • MLST revealed genetic diversity in non-typeable *H. influenzae* (NTHi) from pneumonia and AOM, with specific STs associated with BLNAR. Meningitis cases were dominated by ST54, distinct from the common ST6 in databases.

Conclusions:

  • Non-typeable *H. influenzae* (NTHi) from pneumonia and AOM exhibit significant genetic diversity.
  • *Haemophilus influenzae* type b (Hib) remains predominant in meningitis cases.
  • Confirmed associations between specific STs and β-lactam resistance in NTHi.

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334